Drug Shortage Report for MENACTRA

Last updated on 2018-01-22 History
Report ID 6731
Drug Identification Number 02279924
Brand name MENACTRA
Common or Proper name Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Company Name SANOFI PASTEUR LIMITED
Active Ingredient(s) MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP A MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP C MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP W 135 MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP Y
Strength(s) 4.0 μG 4.0 μG 4.0 μG 4.0 μG
Dosage form(s) Solution
Route of administration INTRAMUSCULAR
Packaging size 5 x 0.5 mL vials
ATC code J07AH
ATC description BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-11-22
Actual start date 2017-11-22
Estimated end date 2018-01-15
Actual end date 2018-01-18
Shortage status Resolved
Updated date 2018-01-22
Company comments Menactra lot# U5988AB was released to the market on January 18, 2018.
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 416-667-2611 or 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2779 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-01-22 French Compare
v8 2018-01-22 English Compare
v7 2018-01-22 French Compare
v6 2018-01-22 English Compare
v5 2017-11-23 English Compare
v4 2017-11-22 French Compare
v3 2017-11-22 English Compare
v2 2017-04-13 French Compare
v1 2017-04-13 English Compare